1. Home
  2. SUPN vs CPRI Comparison

SUPN vs CPRI Comparison

Compare SUPN & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$55.61

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Capri Holdings Limited

CPRI

Capri Holdings Limited

HOLD

Current Price

$19.03

Market Cap

2.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
CPRI
Founded
2005
1981
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.9B
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
SUPN
CPRI
Price
$55.61
$19.03
Analyst Decision
Strong Buy
Buy
Analyst Count
5
14
Target Price
$61.60
$26.50
AVG Volume (30 Days)
740.4K
3.5M
Earning Date
05-21-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.18
Revenue
$392,755,000.00
$4,442,000,000.00
Revenue This Year
$23.19
N/A
Revenue Next Year
$17.65
$1.81
P/E Ratio
N/A
$16.10
Revenue Growth
N/A
N/A
52 Week Low
$29.16
$11.86
52 Week High
$59.68
$28.27

Technical Indicators

Market Signals
Indicator
SUPN
CPRI
Relative Strength Index (RSI) 63.79 34.83
Support Level $47.95 $16.62
Resistance Level $58.67 $19.62
Average True Range (ATR) 2.26 0.95
MACD 0.38 -0.03
Stochastic Oscillator 60.13 17.72

Price Performance

Historical Comparison
SUPN
CPRI

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About CPRI Capri Holdings Limited

Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. John Idol has served as Capri's CEO since 2003.

Share on Social Networks: